Nationwide
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Participants With Moderately to Severely Active Systemic Lupus Erythematosus
UCB Biopharma SRL
Ph 3·~4yr·57 sites in AR, AZ, CA +17
Enrolling now
Check if I qualifyShowing 1–24 of 43 trials
UCB Biopharma SRL
AstraZeneca
AstraZeneca
Luminary Therapeutics
NYU Langone Health
AbbVie
Seattle Children's Hospital
State University of New York - Upstate Medical University
Ventus Therapeutics U.S., Inc.
Novartis Pharmaceuticals
Zenas BioPharma (USA), LLC
AstraZeneca
Terry L. Wahls
GlaxoSmithKline
Hospital for Special Surgery, New York
AstraZeneca